comparemela.com

Latest Breaking News On - Decipher biosciences - Page 6 : comparemela.com

Tina Nova: A daydreamer from Delano who rocketed to San Diego biotech superstardom

Tina Nova: A daydreamer from Delano who rocketed to San Diego biotech superstardom
sandiegouniontribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegouniontribune.com Daily Mail and Mail on Sunday newspapers.

Why Veracyte s Bonnie Anderson is stepping away from the CEO seat — and what she plans to do next

Why Veracyte s Bonnie Anderson is stepping away from the CEO seat — and what she plans to do next
bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.

Cardiff Oncology in Collaboration with MIT Presents Gene Signature Analyses Data Identifying Androgen-Independent Mechanism for Onvansertib-Abiraterone Synergy in mCRPC

Share this article SAN DIEGO, April 10, 2021 /PRNewswire/ Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company developing onvansertib to treat cancers with the greatest medical need for new treatment options, including KRAS-mutated colorectal cancer, pancreatic cancer and castrate-resistant prostate cancer, in collaboration with scientists in the Center for Precision Cancer Medicine at the Massachusetts Institute of Technology (MIT), today announced that new gene signature and mechanistic analyses related to its ongoing Phase 2 trial of onvansertib in metastatic castrate-resistant prostate cancer (mCRPC) were featured in a virtual oral poster presentation at the American Association for Cancer Research (AACR) Annual Meeting 2021.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.